Scalp cooling systems are used to treat hair loss caused by certain chemotherapeutic agents. Scalp cooling/cold caps can be used on all types of solid tumors treated with chemotherapeutic agents such as alkylating agents (e.g. cyclophosphamide), DNA intercalating agents/anthracycline agents (e.g. doxorubicin) and taxanes (e.g. docetaxel) there is. In cancer treatment, these drugs target rapidly dividing cells and keratinocyte matrix, leading to hair loss.
The scalp cooling system works by lowering the temperature of the scalp by a few degrees. It can be used before, during or after administration of chemotherapy. Scalp cooling systems can also reduce hair follicle blood flow to minimize or prevent hair loss. Hair loss is often caused by complete or partial atrophy of the hair root, which causes the hair shaft to contract and break easily.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17527
Cooling is used to slow the metabolism of cells and causes cytotoxicity of chemotherapeutic agents localized to the scalp. The scalp cooling system causes vasoconstriction that reduces blood flow to the scalp, reducing the deposition of chemotherapeutic agents into the hair follicles. This will lower the effective amount that can enter the hair follicles. 220C is the optimum temperature to reduce hair loss. The scalp cooling system is a helmet-like structure with coolant that produces -15 and -40 degrees Fahrenheit.
The market has grown due to growing concerns about alopecia in cancer patients and increasing awareness of scalp cooling systems. The use of scalp cooling systems has been proven to be effective against chemotherapeutic agent-induced hair loss and can result in complete preservation or high levels of hair retention.
For cancer patients, a scalp cooling system provides an opportunity to regain control over alopecia. To date, only two scalp cooling systems have received FDA marketing approval: the 2015 DigniCap system and the 2017 Paxman scalp cooling system. Investments in scalp cooling systems have enabled companies to achieve market-leading technical precision and clinical efficacy. All these factors are driving the rapid growth of the scalp cooling system market.
The limited applicability and low awareness of the cooling system are constraining the growth of the scalp cooling system market.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/17527
Scalp Cooling System Market: Segmentation
End-user base segmentation
- hospital
- clinic
- Outpatient Surgical Center
The global scalp cooling system market has witnessed rapid growth owing to increasing demand for potential health benefits. Manufacturers are focusing more on developing advanced cooling systems to increase acceptance. As the competition in the scalp cooling system market decreases, the company is focusing on developing new technologies for scalp cooling.
The company works with research centers, charities, cancer support groups, healthcare professionals and patients to improve scalp cooling system technology and knowledge base. The future of the scalp cooling system market is expected to grow at a doubling CAGR during the forecast period.
Regionally, the global scalp cooling system market is segmented into North America, Europe, Asia Pacific & Japan, Middle East & Africa region, and Latin America. North America dominates the global scalp cooling system market due to its high acceptance by end users, and in North America due to its high recognition, the United States is the major stakeholder.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/17527
Europe and Asia Pacific are the fastest growing markets for scalp cooling systems market due to growing awareness. The economic situation in the Asia Pacific region has taken the scalp cooling system market to a new level. The Middle East & Africa region and Latin America are also experiencing significant declines in growth during the forecast period due to a lack of knowledge about scalp cooling.
About Us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States United
States Ph.D. – +1-646-568-7751
US-Canada Toll Free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14 / F Tokyo, 130-0013, Japan
Tel 1-888-863-3700
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com